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1. Introduction 
Torsades de pointes is a potentially life threatening form of rapid, polymorphic ventricular 
tachycardia. Literally meaning “twisting of the points”, torsades de pointes is 
electrocardiographically characterized by QRS axis undulations over runs of several beats, 
with a specific twist of the QRS complex around the isoelectric baseline. The definition also 
requires that an abnormal QT-prolongation be present (usually to 600 msec or greater) and / 
or abnormal TU complexes. The arrhythmia usually terminates spontaneously, with the 
exception of rare degeneration into ventricular fibrillation. The episodes are often repetitive 
and frequency dependent. 
In 1966, Dessertenne first described torsades de pointes in a patient with atrio-ventricular 
block (Dessertenne, 1966). Ever since, several reports have associated torsades de pointes 
with bradycardia, especially with atrio-ventricular block (Viskin, 1999). From 5% to 30% of 
patients with atrio-ventricular block have been reported to develop torsades de pointes 
(Motté, 1970, Jensen, 1975,  Guize, 1993) - an observation that suggests the participation of 
yet other intrinsic or extrinsic sensitising factors. 
Most episodes of torsades de pointes are paroxystic, not longer than 5-20 beats, with a very 
elevated heart rate (160-300 bpm). The typical morphology of torsades de pointes includes a 
complete twist at 180° of QRS complexes and a progressive change of the surface ECG. A QT 
interval prolongation to 600 ms or longer is always evident. These episodes are often 
preceded by ventricular bigeminism with fixed and long coupling interval. 
2. Risk factors 
Several studies have proposed different risk factors for torsades de pointes. Among them, 
the most commonly encountered are female gender, advanced age, bradycardia, different 
metabolic disorders, and a number of therapeutic agents (Haverkamp, 2000). The gender-
specific preponderance in females to develop drug-induced torsades de pointes when 
treated with antiarrhythmic drugs or during spontaneous bradyarrhythmias is also well 
documented. In the general population, women have a longer corrected QT interval than 
men. 
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Several endocrine disorders as well as a number of electrolytic imbalances have been 
incriminated as torsades de pointes facilitators (hypothyroidism, mental anorexia, 
hypokalaemia, hypomagnesaemia, hypocalcaemia, acidosis). 
A great number of drugs are currently considered “torsadogenic”. Almost all of these drugs 
have an IKr channel blocking effect, which explains QT interval prolongation. These agents 
belong to both “cardiotropic” and “non-cardiotropic” drugs (an exhaustive list is available 
on Internet at http://www.qtdrugs.org). 
2.1 Atrio-ventricular block – a piece in the puzzle 
The common element between atrio-ventricular block and torsades de pointes seems to be 
the presence of QT interval prolongation. Still, the association between atrio-ventricular 
block and QT interval prolongation is infrequent. Several studies have shown that this exact 
category of patients who present atrio-ventricular block induced – QT prolongation has the 
most elevated risk of developing torsades de pointes. 
 
 
Fig. 1. Holter recording in a patient with post-operative atrio-ventricular block and typical 
torsades de pointes. Note the association of long QT interval, ventricular bigeminism, 
bradycardia, and bradycardia-dependant polymorphic ventricular tachycardia degenerating 
in ventricular fibrillation. 
Kurita et al. have reported that patients with bradycardia-induced torsades de pointes have 
abnormally long QT intervals at slow heart rates, compared with patients with bradycardia 
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but no tachyarrhythmia (Kurita, 1992). Strasberg et al. compared patients with atrio-
ventricular block with torsades de pointes to those without torsades de pointes, and 
mentioned that the QT interval in patients with torsades de pointes was longer than in those 
without torsades de pointes, whereas heart rate and QRS interval during the escape rhythm 
were not significantly different (Strasberg, 1986). Moreover, they reported that QT interval 
above 600 ms and premature ventricular beats on electrocardiogram appear to indicate an 
increased risk for the development of polymorphic ventricular tachycardia in a patient with 
atrio-ventricular block. 
In a retrospective review of 43 young patients with congenital atrio-ventricular block, 
Sholler et al. found QT interval prolongation to be an independent predictor of symptoms, 
including cardiac arrest and syncope. Overall, the outcome was poor with 21% of the 
atrio-ventricular block patients in their symptomatic group with rate-corrected QT 
intervals >0.45 seconds, in contrast with none in the asymptomatic group (Sholler, 1989). 
Marked QT interval prolongation complicated by torsades de pointes, as a sequela of 
acquired atrio-ventricular block, has been convincingly demonstrated in paediatric and 
adult patients. In each of these patients, who ranged in age from 18 months to 80 years on 
initial presentation with torsades de pointes, there was QT interval normalization and 
complete suppression of torsades de pointes after institution of ventricular pacing at age-
appropriate rates. 
Experimental data confirm these observations. In a dog model with chronic atrio-ventricular 
block, the QT interval was prolonged by 20%. 
3. Genetic bases 
3.1 Genetic bases of acquired long QT syndrome 
In contrast to congenital long QT syndrome, the acquired form has been considered a non-
familial disease, which is not transmitted in specific genetic patterns of inheritance. This 
does not automatically exclude genetic components from the pathogenesis of acquired long 
QT syndrome, but it implies that these are only cofactors in the pathogenesis. 
The unpredictability of acquired long QT syndrome, its similarity to the congenital form and 
identification of manifest congenital long QT syndrome in patients with the drug-induced 
form, all suggest a genetic contribution to risk. 
With the identification of mutations in ion channel genes underlying congenital long QT 
syndrome and the investigation of large families, a variable clinical expressivity and 
especially incomplete penetrance have become apparent (Raviña, 2000). In a given family, 
some individuals with a certain mutation have frank long QT intervals, while others with 
the same mutation have normal QT intervals at baseline. In some cases, the latter, who 
represent less than 10% of the patients with acquired long QT syndrome, experience 
torsades de pointes only after intervention of a QT-prolonging stressor. In autosomal 
dominant long QT syndrome (Romano-Ward syndrome), the aspect of incomplete 
penetrance was reported to be approximately 25% in a specific group of families. This raises 
the question of the frequency and importance of silent ion channel gene mutations that may 
become functionally significant in presence of coexisting factors. 
Mutations in KCNE1 and KCNE2, KCNH2, HERG itself, and SCN5A have been identified in 
acquired forms of long QT syndrome (Abbott, 1999). However, the gene in which mutations 
are seen most commonly is KCNQ1, encoding for potassium channel IKs (Donger, 1997, 
Napolitano, 2000, Kubota, 2000). 
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Several frequently occurring polymorphisms have also been described in the long QT 
syndrome population, distributed in nearly all the genes associated with this condition. 
Although these changes are apparently not pathogenic, some can generate individual 
susceptibility to the development of arrhythmia. This is the case of the K897T 
polymorphism in KCNH2 (Crotti, 2005), which is present in up to 15% of the population 
and is linked with susceptibility to certain drugs. Another example is the R1047L 
polymorphism, the second most frequent polymorphism encountered in KCNH2, which 
has been associated with the development of torsades de pointes while using the drug 
dofetilide (Sun, 2004). 
Polymorphisms that confer susceptibility to the development of ventricular arrhythmia have 
also been documented in sodium channel Na1.5. This is the case of the H558R 
polymorphism (Viswanathan, 2003), which is present in up to 30% of the population, or 
S1103Y, found mainly in blacks, with an incidence of nearly 13%, and associated with an 
increased risk of sudden death in childhood (Splawski, 2002, Paulussen, 2004). Most of these 
DNA polymorphisms do not occur in coding regions and may either have no functional 
significance, or modulate expression levels of functionally normal proteins. Other rare 
polymorphisms with minor allele frequencies (1-2%) that have been implicated in drug-
induced torsades de pointes include D85N (KCNE1) (Paulussen, 2004) and T8A (KCNE2) 
(Sesti, 2000). I447 polymorphism in KCR1 was also proposed as potential modulator of the 
risk of drug-induced torsades de pointes (Roden, 2005). The valine variant was seen in 1.1% 
of patients, compared with 7% in controls, suggesting that the presence of valine in this 
position protects against drug-induced torsades de pointes. 
It is not yet clear if all patients with acquired long QT syndrome have a genetic 
predisposition. Systematic evaluation of genes known to be involved in congenital long  
QT syndrome has therefore been recommended in patients with acquired long QT 
syndrome. 
3.2 Genetic bases of atrio-ventricular block-induced torsades de pointes 
A general observation is that only a minority of patients with atrio-ventricular block 
develop torsades de pointes. Moreover, in the early nineties, in patients with atrio-
ventricular block and torsades de pointes compared with those without torsades de 
pointes, it was reported that the QT interval was longer than the bradycardia could 
account for.  These observations suggested a genetic predisposition of the affected 
subjects. Furthermore, common clinical features and the presence of long QT intervals in 
patients with congenital long QT syndrome and in those with atrio-ventricular block–
induced torsades de pointes suggested that patients with atrio-ventricular block-mediated 
QT-related arrhythmia could have latent congenital long QT syndrome or a vulnerable 
genetic polymorphism. 
Moreover, several similarities have been found between experimental models of atrio-
ventricular block–induced torsades de pointes and specific forms of human congenital 
long QT syndrome. Frequent episodes of spontaneous torsades de pointes during day and 
night, abnormal QTU complex, and reduction of both IKr and IKs in a rabbit atrio-
ventricular block model (Tsuji , 2002) closely resemble the clinical characteristics of the 
malignant form of human congenital long QT syndrome caused by double mutation of 
HERG and KCNQ1. An enhanced susceptibility to acquired torsades de pointes, the 
adrenergic dependence of torsades de pointes, the typical T-wave patterns during 
prolonged QT intervals and the reduction of IKs in dog with chronic atrio-ventricular 
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block closely resemble the clinical characteristics of the LQT1 or LQT5 form of human 
congenital long QT syndrome. 
Using recently introduced molecular biology techniques, these bradycardia-related 
repolarisation abnormalities appear to be allelic variants in the coding region of congenital 
long QT syndrome genes, variants that can be identified in 10–15% of affected subjects. A 
recent retrospective study showed that 14% to 18% of subjects with atrio-ventricular block-
related QT-interval prolongation were carriers of a genetic mutation in genes coding for 
potassium channels. Another study showed that 36% of patients with complete atrio-
ventricular block and torsades de pointes had a genetic mutation involving HERG and 
SCN5A (Yoshida, 2001). In fact, the most commonly encountered mutation in this setting is 
in HERG genes, coding for potassium channel IKr. 
The scarcity of this association in the general population is directly responsible for the 
limited amount of information that we dispose of regarding this issue. Still, much is 
expected from future molecular testing in these patients. 
4. Pathophysiology 
4.1 Pathophysiology of torsades de pointes 
The association between torsades de pointes and a prolonged QT interval has long been 
known, but the underlying mechanisms of torsades de pointes have yet to be satisfactorily 
elucidated. In general, alterations in cardiac ion currents which dictate the normal action 
potential play a major role in arrhythmogenesis. Both early afterdepolarisation - induced 
triggered activity (Cosio, 1991, Shimizu,1995, Burashnikov, 2002) and increased dispersion 
of repolarisation have been suggested as playing a role in the genesis of torsades de pointes. 
Significantly increased transmural dispersion of repolarisation favours re-entrant substrates 
that initiate and maintain torsades de pointes. 
QT intervals in humans are very variable, being strongly influenced by age, sex, heart rate 
or heart diseases. It would appear that subjects with a propensity to develop the syndrome 
have a subclinical abnormality in some of the ion channels dictating repolarisation, and / or 
a reduced repolarisation reserve. 
The latter hypothesis has been suggested by Roden et al (Roden, 1998). They hypothesized 
that the extent of QT lengthening in response to specific environmental triggers depends on 
the ventricular “repolarisation reserve”. This concept proposes that loss of one component 
(e.g. IKs) ordinarily will not lead to failure of repolarisation since multiple other currents 
flow across the myocyte membrane (e.g. IKr) also act to maintain repolarisation in normal 
ranges. However, when a reduction or down regulation in any of the currents involved in 
the repolarisation phase is overlapped by a destabilizing factor, this “reserve” is overcome 
and acquired long QT syndrome may become clinically obvious (Roden, 1998). This issue 
may occur in the female gender, when a factor such as bradycardia or hypokalaemia is 
present, in conditions that predispose to electrical remodelling such as heart failure, 
myocardial ischemia, or ventricular hypertrophy. 
It is well known that local action potential duration of myocardial cells displays 
considerable variability depending on many factors, including, in normal conditions, 
location in the ventricular wall (epicardium, mid-myocardium or endocardium) and rate of 
stimulation. These differences in action potential duration across the ventricular wall 
determine the transmural dispersion of repolarisation. When this transmural dispersion is 
exaggerated, opposite voltage gradients may occur and trigger oscillatory potentials, 
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namely phase 2 early afterdepolarisations and sustained abnormal electrical activity 
(Dangman, 1981, Brachmann, 1983, Levine, 1985, Roden, 1985, Davidenko, 1989). 
Rarely, a single severe abnormality in a major repolarizing current can elicit an abnormal 
phenotype, as in congenital long QT syndrome (Roden, 1996). More commonly, one or more 
pre-existing minor abnormalities of repolarisation result in a subclinical phenotype. 
Following recent advances in molecular biology and genetics, it has become clear that in 
some clinical instances (e.g. congestive heart failure or cardiac hypertrophy) ion channel 
genes become down-regulated and the consequent reduced ion currents are likely to cause 
prolonged myocardial repolarisation. If, within this framework, an environmental stressor 
able to further destabilize the “repolarisation reserve” interferes, a long QT syndrome may 
be unburied and the arrhythmic consequences may appear. 
Thus, a potentially dangerous stressor may appear completely safe when present in a large 
number of subjects. The risk may only be evident when the factor is present in a certain 
individual under certain circumstances. 
4.2 Pathophysiology of atrio-ventricular block-induced torsades de pointes 
Although a slow ventricular rate may be a major factor for inducing abnormal QT 
prolongation, the mechanism of QT prolongation in patients with bradycardia-related 
torsades de pointes is poorly understood. 
Farkas et al. showed for the first time that bilateral vagotomy can prevent drug-induced 
torsades de pointes in an in vivo rabbit model, demonstrating that vagally-mediated 
reductions in heart rate are necessary for the development of torsades de pointes (Farkas, 
2008). Torsades de pointes has been described in many conditions associated with 
bradycardia, such as atrio-ventricular block, drugs, vagotonia or hypothyroidism. 
Moreover, the occurrence of torsades de pointes in the presence of bradycardia is influenced 
by other factors such as gender, degree of QT prolongation or duration of bradycardia. 
An interesting observation shows that arrhythmogenic bradycardias are most commonly 
chronic, with a slow ventricular escape rhythm – a profile corresponding to atrio-ventricular 
block. Studies have reported that patients with atrio-ventricular block have significantly 
longer QT intervals than those with sinus bradycardia, even at comparable heart rates. This 
relative QT prolongation may be one of the major reasons that torsades de pointes is more 
commonly observed in chronic atrio-ventricular block than in sinus bradycardia. 
Clinical and experimental data show that the duration of atrio-ventricular block is  
an important determinant of the susceptibility to acquired torsades de pointes. Experimental 
studies show that torsades de pointes is rarely inducible at 0 weeks of atrio-ventricular  
block (acute atrio-ventricular block) but is inducible at 5 weeks (chronic atrio-ventricular 
block) in most animals (Vos, 1998). In a series of 64 patients with chronic atrio-ventricular 
block, Yiginer et al. reported a longer duration of bradycardia in the three patients who 
developed torsades de pointes (Yiginer, 2010). Concomitant to the duration of atrio-
ventricular block, the likelihood of structural and electrical alterations in myocardial cells 
may increase. 
4.2.1 Bradycardia-induced cardiac remodelling 
Atrio-ventricular block-induced volume overload initiates a number of adaptative processes 
that are aimed to compensate the decreased cardiac output and the increased end-diastolic 
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pressure. These remodelling processes offer both the “trigger” and “substrate” for the 
occurrence of torsades de pointes. 
Bradycardia-induced volume overload causes the development of a biventricular eccentric 
hypertrophy and consequently a non-homogenous lengthening of the ventricular action 
potential duration. Exact information concerning the sequence and nature of the time-
related electrophysiological process in hypertrophy are lacking, but there seems to be a 
parallelism between the evolutions of the two processes. These adaptations, alone or 
synergistically, increase the risk of early afterdepolarisations and / or delayed 
afterdepolarisation and therefore the risk of torsades de pointes. 
4.2.2 Structural remodelling during atrio-ventricular block 
Ventricular hypertrophy in this setting is a response of the heart to compensate the altered 
hemodynamic load induced by atrio-ventricular block (Vos, 1998). The process is initiated 
by mechanical factors and thereafter amplified by neurohumoral factors, such as adrenergic 
stimuli, the renin-angiotensin system, endothelin, or insulin-like growth factor. 
Autopsy studies have demonstrated increased heart weight to body weight ratios, with 
significant contributions of both the right and left ventricular mass. Morphologically, 
biventricular hypertrophy is characterized by an eccentric expansion with increased right 
and left ventricular diameters, as seen during volume overload (Verduyn, 2001). Photo- and 
electron-micrograph analyses have shown myocardial cell hypertrophy together with the 
parallel increases of collagen fibbers and extracellular space. 
Morphopathological studies have shown larger growth responses in the right than left 
ventricular myocytes, supporting the autopsy finding of a larger relative increase of the 
right than the left ventricular weight, as well as a more significant hypertrophy of right 
ventricular free wall and septal wall than of the left ventricular free wall (Verduyn, 2001, 
Sugiyama, 2002). The preponderance of right ventricular cell growth in atrio-ventricular 
block may reflect a greater impact on this chamber after the transition from sinus rhythm to 
idioventricular rhythm. 
This structural adaptation process is accompanied by electrophysiological remodelling. 
Prolongation of the left ventricular action potential is a consistent observation in myocardial 
hypertrophy of different causes in several species. Many of the sarcolemmal ion channels, 
exchangers, and pumps, as well as intracellular ion transporters, can show functional 
defects leading to delayed repolarisation. 
4.2.3 Electrical remodelling during atrio-ventricular block 
While electrical and structural changes in chronic atrio-ventricular block are aimed to 
maintain cardiac function, they also predispose to QT prolongation, leading to the onset of 
torsades de pointes. This association has been extensively evaluated in animal studies. 
Tsuji et al. reported the results obtained in a rabbit model with atrio-ventricular block 
induced by injection of formaldehyde into the atrio-ventricular node (Tsuji, 2002). These 
rabbits received ventricular pacing support after atrio-ventricular block induction. The 
authors demonstrated significant QT interval prolongation in the same day that they 
discontinued pacing, with further prolongation later on. Seventy % of the animals 
developed spontaneous torsades de pointes, with most episodes occurring during the first 
week of uncompensated bradycardia. Even more information has been offered by a rabbit 
model with atrio-ventricular block induced by transcatheter radiofrequency ablation of 
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atrio-ventricular node. Chronic endocardial ventricular pacing at near-physiologic rate was 
installed immediately after the ablation procedure. The authors showed identical 
amplitudes of all repolarizing currents in atrio-ventricular block group and sham-operated 
group. Moreover, they showed a similar down-regulation in the affected currents regardless 
of ventricular cavity stimulation (left or right ventricle) and they concluded that secondary 
electrical remodelling is unrelated to the loss of atrio-ventricular synchrony, suggesting that 
bradycardia alone suffices to turn on the electrical remodelling process. 
In vivo experiments in dogs indicate the importance of bradycardia-dependent early 
afterdepolarisations, increased regional dispersion of repolarisation and multiple ectopic 
beats for the initiation of torsades de pointes. Fast heart rates tend to oppose these actions, 
preventing torsades de pointes. 
Several mechanisms have been proposed for early afterdepolarisations occurrence in this 
setting (Emori, 2001, Yan, 2001). These abnormalities appear to be secondary to both 
bradycardia-dependent depression of electrogenic Na+ pumping and more complete 
inactivation of K+ currents. Vos et al. showed a high incidence of early afterdepolarisations 
in dogs with chronic atrio-ventricular block after d-sotalol administration and proposed 
significant down-regulation of the slow component of the delayed rectifier K+ current (IKs) 
and that of the rapid component (IKr) as potential mechanism (Vos, 1995, 1998). 
Enhanced regional dispersion of repolarisation is considered to be the consequence of 
inhomogeneous prolongation of ventricular action potential (more in the left than the right 
ventricle), probably reflecting the existence of significant repolarisation gradients in closely 
adjacent areas, possibly the septum. Interventricular differences of the action potential are 
known to exist in the normal myocardium of dogs with sinus rhythm. In chronic atrio-
ventricular block, larger action potential durations have been documented in left mid-
myocardial compared with right ventricular myocytes, in contrast to the larger degree of 
hypertrophy in the latter. The observation that a down-regulation of IKs is present in both 
ventricles while IKr down-regulation is mainly expressed in the right ventricle could explain 
these abnormalities. 
Other currents such as It0, ICaL or IK1 have been reported as unchanged in a number of 
studies. 
However, the observations are contradictory. While some suggest that the role of It0  
is unlikely given the fact that the spike-and-dome configuration of the action potential  
is preserved, others suggest that low ventricular rates are associated with submaximal 
activation of It0, which would shift the plateau phase of the action potential to voltage  
levels in which Ca2+ window current availability is increased, predisposing to torsades de 
pointes. 
The fact that the action potential duration to 95% of complete repolarisation and action 
potential duration to 50% of complete repolarisation have been found to be increased to a 
similar extent indicates that the delay of repolarisation is most likely due to a disturbance at 
the plateau level, sustaining the central role of IKr and IKs in this setting. 
Additional insights into the ionic mechanisms of action potential prolongation in chronic 
atrio-ventricular block come from experiments with almokalant. After block of IKr during 
almokalant treatment, the action potential duration was found much larger in chronic atrio-
ventricular block myocytes than in sinus rhythm controls. This suggests that ionic currents 
other than IKr contribute to the abnormal repolarisation in chronic atrio-ventricular block, 
even though the role of IKr can not be excluded. These results have been confirmed by other 
similar studies, which show uniformly distributed IKs down-regulation by 50% in both 
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ventricles, while a similar degree of IKr inhibition was apparent only in the right but not in 
the left ventricle. 
In vivo recordings in dog with chronic atrio-ventricular block demonstrate that another 
important factor involved in the occurrence of torsades de pointes is represented by 
ventricular ectopic beats. However, their origin and mechanisms remain obscure for the 
moment. 
5. Conclusions 
Investigations of the clinical aspects and molecular mechanisms of long QT syndrome have 
provided novel and important insights into the basis of ventricular arrhythmias and shown 
how small perturbations in ion flow can have important consequences in human health. 
Even if molecular diagnosis appears to be an appealing way of integrating contemporary 
genomics with arrhythmia science, several obstacles limit its wide availability. Molecular 
diagnosis is restricted by the very large number of candidate genes and the correspondingly 
huge number of described polymorphisms. Moreover, most association studies have not 
proven to be reproducible, raising the problem of false positives. There is also the issue that, 
owing to its restrictive costs, mutation screening will be limited to a limited number of 
specialized centres for some time. 
Though great progress has been made, many important issues require further clarification. 
A major challenge in the future will be to understand the complex mechanisms of 
repolarisation and to assess the individual risk of malignant arrhythmia more precisely. 
Moreover, mutations in other ion channel genes, still unrecognized, could be responsible for 
different variants of long QT syndrome. 
We recommend systematically genotyping patients with acquired long QT syndrome and 
torsades de pointes. The next step could be represented by case-control studies of gene 
polymorphisms in pace-maker patients to find the possible markers of susceptibility to 
malignant arrhythmias during bradycardia. 
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